RIGEL PHARMACEUTICALS INC (RIGL) Stock Earnings & Estimates
USA - NASDAQ:RIGL - US7665597024 - Common Stock
28.055 USD
-0.05 (-0.2%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 120.2M -19.44% | 116.882M -2.76% | 179.278M 53.38% | 286.72M 59.93% | 282.55M -1.45% | 297.84M 5.41% | 313.08M 5.12% | 346.6M 10.71% | 382.09M 10.24% | 461.58M 20.80% | 448.49M -2.84% | |
| EBITDA YoY % growth | -53.3M -579.85% | -19.253M 63.88% | 26.42M 237.23% | 115.02M 335.35% | 125.64M 9.23% | 134.04M 6.69% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -54.3M -503.33% | -20.491M 62.26% | 24.192M 218.06% | 111.06M 359.08% | 85.528M -22.99% | 81.383M -4.85% | 69.416M -14.70% | 85.03M 22.49% | 110.73M 30.22% | 154.25M 39.30% | 109.75M -28.85% | |
| Operating Margin | -45.17% | -17.53% | 13.49% | 38.73% | 30.27% | 27.32% | 22.17% | 24.53% | 28.98% | 33.42% | 24.47% | |
| EPS YoY % growth | -3.40 -209.09% | -1.50 55.88% | 0.94 162.67% | 5.67 503.10% | 3.85 -32.05% | 3.99 3.67% | 2.98 -25.34% | 3.47 16.42% | 4.42 27.33% | 5.56 25.89% | 4.77 -14.21% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.87 24.55% | 0.76 -4.80% | 0.52 -17.43% | 0.59 -81.96% | 0.64 -26.29% | 0.68 -10.27% |
| Revenue Q2Q % growth | 63.117M 14.12% | 66.06M 14.70% | 58.155M 9.04% | 60.226M -40.77% | 63.633M 0.82% | 65.158M -1.37% |
| EBITDA Q2Q % growth | 19.683M 25.53% | 20.808M 10.19% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 17.453M 24.17% | 16.319M -2.02% | 10.705M -16.19% | 12.185M -80.06% | 13.128M -24.78% | 13.511M -17.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 3.28 5,566.67% | 2.63 | 0.65 | 24.64% |
| Q1 2025 Q2Q % growth | 0.63 226.00% | 0.09 | 0.54 | 592.43% |
| Q4 2024 Q2Q % growth | 0.80 | 0.48 | 0.32 | 67.95% |
| Q3 2024 Q2Q % growth | 0.70 333.33% | 0.06 | 0.64 | 1,076.54% |
| Q2 2024 Q2Q % growth | -0.06 85.00% | -0.30 | 0.24 | 79.85% |
| Q1 2024 Q2Q % growth | -0.50 37.50% | -0.29 | -0.21 | -70.03% |
| Q4 2023 Q2Q % growth | 0.00 -100.00% | -0.31 | 0.31 | 100.00% |
| Q3 2023 Q2Q % growth | -0.30 72.73% | -0.72 | 0.42 | 58.57% |
| Q2 2023 Q2Q % growth | -0.40 50.00% | -0.80 | 0.40 | 49.72% |
| Q1 2023 Q2Q % growth | -0.80 50.00% | -0.99 | 0.19 | 19.56% |
| Q4 2022 Q2Q % growth | 0.10 107.69% | -1.14 | 1.24 | 108.74% |
| Q3 2022 Q2Q % growth | -1.10 8.33% | -1.37 | 0.27 | 19.78% |
| Q2 2022 Q2Q % growth | -0.80 | -1.25 | 0.45 | 36.08% |
| Q1 2022 Q2Q % growth | -1.60 -172.73% | -1.40 | -0.20 | -14.26% |
| Q4 2021 Q2Q % growth | -1.30 -18.18% | -1.30 | 0.00 | 0.17% |
| Q3 2021 Q2Q % growth | -1.20 -50.00% | -1.02 | -0.18 | -18.04% |
| Q2 2021 Q2Q % growth | -0.80 20.00% | -1.17 | 0.37 | 31.40% |
| Q1 2021 Q2Q % growth | 2.20 69.23% | 0.05 | 2.15 | 4,365.55% |
| Q4 2020 Q2Q % growth | -1.10 -10.00% | -1.16 | 0.06 | 5.13% |
| Q3 2020 Q2Q % growth | -0.80 -14.29% | -1.24 | 0.44 | 35.56% |
| Q2 2020 Q2Q % growth | -1.00 16.67% | -1.36 | 0.36 | 26.52% |
| Q1 2020 Q2Q % growth | 1.30 218.18% | 1.34 | -0.04 | -3.13% |
| Q4 2019 Q2Q % growth | -1.00 | -0.83 | -0.17 | -20.83% |
| Q3 2019 Q2Q % growth | -0.70 | -1.12 | 0.42 | 37.69% |
| Q2 2019 Q2Q % growth | -1.20 | -1.39 | 0.19 | 13.49% |
| Q1 2019 Q2Q % growth | -1.10 | -1.36 | 0.26 | 18.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 101.685M 176.01% | 90.726M | 10.959M | 12.08% |
| Q1 2025 Q2Q % growth | 53.333M 80.58% | 44.752M | 8.581M | 19.17% |
| Q4 2024 Q2Q % growth | 57.596M 60.92% | 52.766M | 4.83M | 9.15% |
| Q3 2024 Q2Q % growth | 55.307M 96.58% | 42.766M | 12.541M | 29.32% |
| Q2 2024 Q2Q % growth | 36.841M 37.03% | 34.088M | 2.753M | 8.08% |
| Q1 2024 Q2Q % growth | 29.534M 13.29% | 31.91M | -2.376M | -7.45% |
| Q4 2023 Q2Q % growth | 35.792M -30.20% | 34.784M | 1.008M | 2.90% |
| Q3 2023 Q2Q % growth | 28.134M 25.54% | 27.745M | 389K | 1.40% |
| Q2 2023 Q2Q % growth | 26.886M -9.84% | 26.218M | 668K | 2.55% |
| Q1 2023 Q2Q % growth | 26.07M 55.73% | 24.554M | 1.516M | 6.17% |
| Q4 2022 Q2Q % growth | 51.28M 151.25% | 28.527M | 22.753M | 79.76% |
| Q3 2022 Q2Q % growth | 22.41M 4.04% | 23.062M | -652K | -2.83% |
| Q2 2022 Q2Q % growth | 29.82M 13.51% | 24.128M | 5.692M | 23.59% |
| Q1 2022 Q2Q % growth | 16.74M -79.34% | 17.895M | -1.155M | -6.45% |
| Q4 2021 Q2Q % growth | 20.41M 10.62% | 22.337M | -1.927M | -8.63% |
| Q3 2021 Q2Q % growth | 21.54M 17.13% | 24.033M | -2.493M | -10.37% |
| Q2 2021 Q2Q % growth | 26.27M 63.98% | 20.777M | 5.493M | 26.44% |
| Q1 2021 Q2Q % growth | 81.02M 45.30% | 31.672M | 49.348M | 155.81% |
| Q4 2020 Q2Q % growth | 18.45M 19.81% | 18.463M | -13K | -0.07% |
| Q3 2020 Q2Q % growth | 18.39M -11.84% | 17.58M | 810K | 4.61% |
| Q2 2020 Q2Q % growth | 16.02M 53.89% | 14.024M | 1.996M | 14.23% |
| Q1 2020 Q2Q % growth | 55.76M 341.84% | 57.841M | -2.081M | -3.60% |
| Q4 2019 Q2Q % growth | 15.4M | 15.969M | -569K | -3.56% |
| Q3 2019 Q2Q % growth | 20.86M | 16.708M | 4.152M | 24.85% |
| Q2 2019 Q2Q % growth | 10.41M | 9.467M | 943K | 9.96% |
| Q1 2019 Q2Q % growth | 12.62M | 11.602M | 1.018M | 8.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 307.02% | 0% | 380.48% |
| Revenue | 0% | 22.41% | 0% | 39.78% |